While it may be too early to judge the world-wide race to beat covid-19, the neighboring countries of South Korea Japan so far seem to be doing relatively better than many other nations. Non-policy factor such as their cultural habits probably explains great deal, but how both the government and companies in both countries reacted to covid-19 in terms of medical response deserve analysis, as both countries move along the exit path.
How is the healthcare industry in two countries dealing with the crisis? What was the response in Japan and Korea for the coronavirus and how different were they? What are the to do/not to do in their exit process? When will the treatment or vaccine be available? What are the healthcare restrictions that society needs to endure until we get the pandemic fully under control?
Join our Webinar on Monday, May 18 at 16:30-17:30 as we invite the leading experts to explore and compare the details of the covid-19 pandemic in Japan and Korea.
Chairman & CEO of Healios K.K.
Chief Strategy Officer at SugenTech
Executive Director, Research of Morgan Stanley Korea
Director, Corporate Network, North Asia of The Economist Corporate Network
Associate Director, ECN North Asia of Economist Corporate Network